Bella Pharmaceuticals Recalls Magnesium Chloride Vials Due to Sterility Concerns
Bella Pharmaceuticals is recalling Magnesium Chloride 200mg vials because the company cannot ensure the product is sterile.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable medication, which poses a significant risk of serious injury or infection.
Plain-English summary
Bella Pharmaceuticals, Inc. is recalling Magnesium Chloride 200mg, 30mL vials (Lot #: BPMC08517, Exp. 2/5/18). The recall was initiated due to a lack of assurance of sterility.
The affected product is prescription-only and was distributed nationwide within the USA. The recall involves 5 vials per unit.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or Bella Pharmaceuticals for further instructions.
The recalled product
- Product
- Magnesium Chloride 200mg, 30m L vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.
- Manufacturer
- Bella Pharmaceuticals, Inc.
- Category
- Drug — Injectable Medication
- Affected units
- 5
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: BPMC08517
- Exp. 2/5/18
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Bella Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Bella Pharmaceuticals, Inc.
See all →- SevereBella Pharmaceuticals Recalls Mannitol 20% Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls B-Complex Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls Fluorescein Sodium Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls L-Glutamine Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls PF-Glutathione Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
Same hazard · infection
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- HighSurgipro Sutures Recalled for Potential Sterile Barrier Perforation
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19